Clinical Trials Directory

Trials / Conditions / Allogeneic Hematopoietic Cell Transplantation

Allogeneic Hematopoietic Cell Transplantation

8 registered clinical trials studyying Allogeneic Hematopoietic Cell Transplantation — 2 currently recruiting.

StatusTrialSponsorPhase
RecruitingPrecision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
NCT05501756
Children's Hospital Medical Center, CincinnatiPhase 2
RecruitingStudy of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell Transplantation
NCT04332341
Case Comprehensive Cancer CenterEARLY_Phase 1
TerminatedXylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients
NCT04117477
Children's Hospital Medical Center, CincinnatiPhase 2
TerminatedTCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disor
NCT04088760
Children's Hospital Medical Center, CincinnatiPhase 2
CompletedA Study of FMT in Patients With AML Allo HSCT in Recipients
NCT03678493
Masonic Cancer Center, University of MinnesotaPhase 2
CompletedPrecision Dosing of Alemtuzumab
NCT03302754
Children's Hospital Medical Center, CincinnatiN/A
UnknownThe Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantati
NCT02506231
Rabin Medical CenterPhase 2 / Phase 3
CompletedIron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT00888316
Masonic Cancer Center, University of Minnesota—